Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001400568-25-000005

Director sold 43,684 shares at $29.31 ($1,280,465)

  • Director acquired 43,684 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wendell Amy McBride · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-16 Exercise or conversion : show line 1 in the form +5,000 $8.95 $44,750 98,826 D
2025-12-16 Exercise or conversion : show line 2 in the form +20,436 $6.30 $128,747 119,262 D
2025-12-16 Exercise or conversion : show line 3 in the form +18,248 $7.04 $128,466 137,510 D
2025-12-16 Sale : show line 4 in the form −5,000 $29.31 $146,560 132,510 D
2025-12-16 Sale : show line 5 in the form −20,436 $29.31 $599,020 112,074 D
2025-12-16 Sale : show line 6 in the form −18,248 $29.31 $534,885 93,826 D
Open-market sales · 43,684 sh · avg $29.31 · $1,280,465

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-12-16 Exercise or conversion : show line 7 in the form Stock Option (right to purchase) −5,000 0 D
2025-12-16 Exercise or conversion : show line 8 in the form Stock Option (right to purchase) −20,436 0 D
2025-12-16 Exercise or conversion : show line 9 in the form Stock Option (right to purchase) −18,248 0 D
Loading xslF345X05/wk-form4_1766006718.xml…